Professor Mary J. Meegan
Prof. Mary J. Meegan Ph.D., M.A.,MRSC, CChem, FTCD.
Location: Panoz Institute, Trinity College, Dublin 2, Ireland. Trinity Biomedical Sciences Institute (TBSI), 152-160 Pearse Street, Dublin 2, Ireland.
Mary J Meegan was appointed Associate Professor of Pharmaceutical Chemistry in the School of Pharmacy and Pharmaceutical Sciences in 2007. She received her BSc and PhD degrees in chemistry from University College Dublin (NUI) and subsequently carried out postdoctoral research in the areas of porphyrin biosynthesis at the University Chemical Laboratory, Cambridge and flavonoid natural product synthesis in the Chemistry Department, University College Dublin and was visiting research fellow at CNRS, Gif-sur-Yvette. Her current research interests are focussed on the areas of design and synthesis of new anticancer drugs resulting in the discovery of novel bioactive molecules, such as nuclear receptor antagonists, tubulin targeting agents and multidrug resistance modulators. The focus of research is in the application of modern organic synthesis, medicinal chemistry and in silico virtual high-throughput screening for design, synthesis and evaluation of highly potent and selective molecular structures which may be developed as therapeutic agents for the treatment of breast cancer, prostate cancer and lymphomas.
Since joining the School of Pharmacy in 1979, she has published over 80 papers in the field of pharmaceutical and medicinal chemistry. Prof. Meegan’s expertise covers the major areas of Pharmaceutical and Medicinal chemistry, with special emphasis on development of novel methodologies in drug design. Research is funded by Health Research Board, Centre for Synthesis and Chemical Biology (CSCB) and Enterprise Ireland.
Health Research Board, Centre for Synthesis and Chemical Biology (CSCB) and Enterprise Ireland.